science

Karin M. Hehenberger

Karin M. Hehenberger is a science topic covered in the lgStudy science library. This page brings together a partial reference excerpt, illustrations, worked examples, real-world applications and a short study plan, so you can understand Karin M. Hehenberger rather than just read about it. In short: Karin M. Hehenberger (born 1973) is a Swedish physician, investor, business executive, and diabetes expert, known for her work in the field of biotechnology.

Key takeaways

Karin M. Hehenberger belongs to science; place it in that map before memorising details.
Learn the definition first, then one example that makes the definition concrete.
Connect Karin M. Hehenberger to a quantity you can measure, compute or draw — that is where exam questions come from.
Reproduce the core statement of Karin M. Hehenberger from memory before moving on to harder problems.

Reference excerpt

Karin M. Hehenberger (born 1973) is a Swedish physician, investor, business executive, and diabetes expert, known for her work in the field of biotechnology. She has written numerous articles on biotechnology that have been published in peer review journals and worked as an executive for different biotechnology companies and investment firms. She is a faculty member in the department of Molecular Medicine at the Karolinska Institute where she also obtained her M.D. and a Ph.D. in molecular medicine. She has lectured on the topics of autoimmune diseases, diabetes, molecular medicine and industry challenges as well as provided commentary for Fox News, Good Morning America Health, New York One, the USA Today and Forbes.

Early life and education Hehenberger is originally from Sweden and played for the Swedish National tennis team. At the age of 16, she was playing tennis internationally when she was diagnosed with Type 1 diabetes, ending her tennis career. Her experience with diabetes led her to pursue a career fighting autoimmune diseases. Hehenberger attended the Karolinska Institutet in Stockholm, Sweden, where she earned her M.D. and Ph.D. in molecular medicine. She went on to a post-doctoral fellowship with the Joslin Diabetes Center at Harvard Medical School. In 2009, she received a kidney transplant from her father, after her kidneys had less than 10 percent total capacity, and in 2010 she received a transplanted cadaver pancreas. The kidney surgery saved her from needing dialysis, while the pancreas surgery rendered her free of diabetes, no longer needing to inject insulin.

Career Hehenberger's career has been spent both in research and on the business side of medicine. She began her career as a consultant at McKinsey & Company, where she consulted on projects relating to healthcare, with an emphasis on diabetes. Hehenberger was also a senior analyst at two multi-billion dollar hedgefunds in the U.S. and Europe, and a partner in a venture capital firm in Europe, gaining experience in public and private equity. She was also a member of the senior management team for Eyetech Pharmaceuticals, which she helped take public in 2004. Hehenberger was also previously the Vice President of Metabolic Strategy and Business Development at Johnson & Johnson. She led the Johnson & Johnson Metabolic Task Force and was responsible for developing the company's strategies for its metabolic disease efforts. She joined the Juvenile Diabetes Research Foundation (JDRF) in December 2009 as its Senior Vice President for Strategic Alliances. Following her time at the JDRF, Hehenberger served as the Executive Vice President of Scientific Affairs and Chief Medical Officer at Coronado Biosciences, Inc., a publicly traded biopharmaceutical company that develops immunotherapy biologic agents for autoimmune diseases and cancer. During her career, she has written articles in peer review journals and has also been a panelist for medical conferences, including BioEurope, MassBio, BioCEO, Alliance for Regenerative Medicine, BioPharm America and the Swedish-American Life Science Summit. Karin Hehenberger sits on the Board of the public Swedish drug development company Diamyd Medical https://www.diamyd.com/Default.aspx, which is developing an antigen-specific precision medicine immunotherapy for the prevention and treatment of Type 1 Diabetes and is conducting a registrational Phase 3 clinical trial in the United States and Europe.

Select publications 1999, Impaired proliferation and increased L-lactate production of dermal fibroblasts in the GK-rat, a spontaneous model of non-insulin dependent diabetes mellitus 1998, Fibroblasts derived from human chronic diabetic wounds have a decreased proliferation rate, which is recovered by the addition of heparin 1998, Inhibited proliferation of fibroblasts derived from chronic diabetic wounds and normal dermal fibroblasts treated with high glucose is associated with increased formation of l-lactate 1997, High glucose-induced growth factor resistance in human fibroblasts can be reversed by antioxidants and protein kinase C-inhibitors 1996, Long-term treatment of Swiss 3T3 fibroblasts with dexamethasone attenuates MAP kinase activation induced by insulin-like growth factor-I (IGF-I)

References

External links Lyfebulb official website Karin M. Hehenberger on Google Scholar

Worked examples

Example 1 — a first encounter with Karin M. Hehenberger

Start with the simplest possible case. Write down what Karin M. Hehenberger claims or describes in one sentence, then invent the smallest concrete situation in which that sentence is true. In science, the smallest case is usually a single object, a single equation or a single measurement. Check that every symbol or term in your sentence has a meaning in that case.

Example 2 — changing one variable

Take the situation from Example 1 and change exactly one quantity: double it, halve it, or set it to zero. Predict what should happen to Karin M. Hehenberger before you calculate. Comparing your prediction with the result is the fastest way to find out whether you understand the idea or only the words.

Example 3 — an exam-style question

Typical questions about Karin M. Hehenberger ask you to (a) state it precisely, (b) apply it to given data, and (c) explain a limitation. Practise writing all three answers in under five minutes; the third part is what separates a full-mark answer from an average one.

Applications of Karin M. Hehenberger

In research: Karin M. Hehenberger appears in science research whenever the underlying quantities have to be modelled precisely. Papers usually cite it as a starting assumption and then explore where it breaks down.
In technology and industry: Engineering practice reuses Karin M. Hehenberger in design rules, simulations and safety margins. Knowing the idea lets you read a specification sheet and understand why the numbers look the way they do.
In the classroom: Karin M. Hehenberger is common in secondary-school and first-year university syllabi. It links to neighbouring topics Harvard Medical School people, Karolinska Institute alumni, Kidney transplant recipients, so understanding it makes those chapters shorter.
In everyday life: Look for Karin M. Hehenberger outside the textbook — in sport, cooking, traffic, electronics or the sky above you. An example you found yourself is remembered far longer than one you were given.

Ask Teacher Smith questions about this articleOpens your AI tutor with a question about “Karin M. Hehenberger” →

Affiliate

Preply — study more efficiently by working with a personal tutor. 50% off.

How to study Karin M. Hehenberger in 20 minutes

Read the reference excerpt below once, without taking notes.
Close the page and write down what Karin M. Hehenberger means in your own words.
Compare your version with the excerpt and mark what you missed.
Work through the three examples above with pen and paper.
Explain Karin M. Hehenberger out loud to somebody else — or to Teacher Smith in the lgStudy chat.

Frequently asked questions

What is Karin M. Hehenberger in simple terms?

Karin M. Hehenberger (born 1973) is a Swedish physician, investor, business executive, and diabetes expert, known for her work in the field of biotechnology.

Why does Karin M. Hehenberger matter?

Because it connects several science ideas at once: it gives you a definition you can apply, a quantity you can calculate, and a way to check whether a result is plausible.

How should I study Karin M. Hehenberger?

Read the excerpt, restate it from memory, then work through the examples and applications listed on this page. The five-step study plan above takes about twenty minutes.

What does this page cover?

It gives you a compact reference excerpt plus original lgStudy explanations, examples, applications and study material on Karin M. Hehenberger.